Eastman Chemical Co: Stock Price Still has Room to Grow

Author's Avatar
Oct 20, 2014
Article's Main Image

Overview

Eastman Chemical Company (EMN, Financial) is a global specialty chemical company. Its products range from base and high precision plastics, chemicals, and fibers, most of which are integrated into the products and processes of other firms in virtually all industries everywhere, including food and beverage packaging, toys, medical equipment, computer hardware components, construction materials, and electronic devices. The company was spun-off from Eastman Kodak in 1993 and, fortunately, is no longer tied to the photography business. Some of its key products include yarns, chemical solutions for water treatments, adhesives, inks, paints, wood preservatives, polymers, resins, and apparel fibers. EMN's full product line is enormous, and to fully understand each item would require a degree in chemistry. That being said, EMN faces perpetual market demand for its products and has a strong repeat revenue business model.

The company's products and operations are managed and reported in five reporting segments:

  • Additives & Functional Products (18% of revenues) include chemicals for products in the coatings and tires industries in transportation, building and construction, durable goods, and consumables markets.
  • Adhesives & Plasticizers (14% of revenues) include resins and plasticizers used in the manufacture of packaging materials, construction adhesives, interior flooring, glove applications, and medical devices.
  • Advanced Materials (25% of revenues) include polymers, films, and plastics for cosmetic packaging, housewares, appliances, and window films.
  • Fibers (16% of revenues) include plasticizers for use in cigarette filters, yarns for use in apparel, home furnishings, and industrial fabrics.
  • Specialty Fluids & Intermediates (27% of revenues) include paint/coating applications, construction chemicals, and other chemicals for building materials and cleaning solutions.

EMN's products represent vital inputs into the production processes of many other firms and, as such, it is not dependent on any particular buyer or sector for revenues. Basically, when the overall global economy grows, EMN's revenues grow. As such, last year was particularly good for EMN with earnings leaping ahead of pre-recessionary levels.

Solutia (a specialty chemicals maker) proved to be a fantastic acquisition for EMN and will continue to support growth. EMN has also recently sold off underperforming plastic facilities and management appears well focused on higher margin activities (i.e. feedstock production). Stability in petroleum prices (EMN's key production input) will also provide gross margin support moving forward. We like that management is expanding the firm's global manufacturing presence, establishing production facilities in Korea and China. Serving these market and maintaining cost parity with international competitors is absolutely critical to EMN's future success.

What's most concerning about EMN is its close ties to manufacturing and commodity price cycles, which can quickly take their toll on revenues. While petroleum prices have been accommodating recently, quick spikes in prices can devastate margins. Competition is also fierce along many of its product lines. There is a lot of uncertainty surrounding environmental regulations and the cost of remediation and chemical capture laws.

Historical Financial Performance

About $9,350M in revenue moved through EMN's door in 2013. EMN’s revenues are closely tied to the business cycle, and for the Dec 2004 to Dec 2013 period, clocked in at an average annual rate of growth of 4%. Revenues grew at an annual rate of 17% over the last 3 years and 7% annually over the last 5 years. This has been driven by acquisition activities, an improvement in the economy, and improved levels of international manufacturing production. Year-over-year, EMN continues to make substantial sums of money off revenues after subtracting costs of goods sold, with gross profits reaching $2,776M in 2014. Gross profits have grown by 12% per year over the last 10 years and 20% per year over the last 5 years.

EMN's production costs appear well under control, with COGS rising by 2% per year over the last 10 years against revenue growth of 4%. EMN does not appear to be experiencing any difficulties passing on the cost of inflation to consumers. Gross margins have expanded from 15% in 2004 to 30% in 2013. In addition to being on an upward trend, EMN's gross margins are reasonably strong (averaging 21%). As a general rule, we want to see consistent gross profit margins above 30% for firms in the sector. While EMN has not been able to meet this requirement in any of the last 10 years, gross profits margins consistently between 15% and 20% for firms in the sector is, in our opinion, indicative of a firm with a reasonably strong competitive advantage and moderate pricing power.

EMN spends about 25% of gross profits on hard costs associated with selling expenses, advertising, management salaries, payrolls, advertising and legal fees. We consider spending 25% of gross profits on SG&A a very good result. Cost of SG&A, however, have been increasing, rising by 4% per year over the last 10 years and 14% per year over the last 3 years. That being said, we consider this an acceptable result when viewed against annual revenue growth of approximately 4% and 17% over the same periods respectively.

EMN has shown continued strength and reasonable stability in its operating earnings picture, rising by 30% per year over the last 10 years and by 29% per year over the last 5 years. The long-term trend in operating income has been upward, rising from $175M in 2004 to $1,862M in 2013. EMN has earned on average about 10% in operating earnings on total revenues over the last 10 years -- an acceptable result. EMN carries a substantial amount of debt on its books and pays out about 10% of operating income on interest payments annually. This is a poor result, though consistent with much of the competition.

Bottom line results show a strong upward long-term trend in earnings, with definite cyclical volatility, growing at an average annual rate of 24% over the last 10 years. Earnings are expected to tick upwards in 2014 and 2015 as the global economy continues to improve. EMN’s reasonably strong competitive position has allowed it to maintain net margins of about 6% over the last 10 years. We do not expect to see much margin expansion from this company over the short- to medium-term.

Diluted EPS grew from $1.09 per share in 2004 to $7.44 in 2013. Since 2004, earnings growth has outpaced revenue growth by 20% per year. To us, this is a sign of earnings quality strength. We dislike, however, that the firm's share-base has not fallen over the last 10 years and remains at about 156M. EMN's ROE performance has been exceptional, averaging 24% over the last 10 years. Its ROA performance has been moderate averaging 7%.

Table 1: Key Financials

Income Statement Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Revenues 6580 6460 6779 6830 6726 4396 5842 7178 8102 9350
% Change - -2% 5% 1% -2% -35% 33% 23% 13% 15%
COGS 5602 5100 5514 5638 5600 3364 4383 5609 6340 6574
Gross Profit 978 1360 1265 1192 1126 1032 1459 1569 1762 2776
SG&A 450 439 423 420 419 367 434 481 644 645
% of Revenues 7% 7% 6% 6% 6% 8% 7% 7% 8% 7%
Operating Income 175 740 654 504 519 345 844 937 800 1862
% Change - 323% -12% -23% 3% -34% 145% 11% -15% 133%
% of Revenues 3% 11% 10% 7% 8% 8% 14% 13% 10% 20%
Interest Expense 115 113 102 103 70 78 99 76 143 180
% of Operating Income 66% 15% 16% 20% 13% 23% 12% 8% 18% 10%
Net Income 170 557 409 300 346 136 425 646 437 1165
% of Revenues 3% 9% 6% 4% 5% 3% 7% 9% 5% 12%
          Â
EPS (Diluted) 1.09 3.405 2.455 1.79 2.275 0.925 2.88 4.52 2.93 7.44
          Â
Balance Sheet          Â
Cash 325 524 939 888 387 793 516 777 249 237
Receivables 675 575 682 546 275 277 545 632 846 880
% of Revenues 10% 9% 10% 8% 4% 6% 9% 9% 10% 9%
Inventories 582 671 682 539 637 531 619 779 1260 1264
% Change - 15% 2% -21% 18% -17% 17% 26% 62% 0%
Current Assets 1768 1924 2422 2293 1423 1735 2047 2302 2699 2840
Total Assets 5839 5773 6132 6009 5281 5515 5986 6184 11710 11845
Current Liabilities 1099 1051 1059 1122 832 800 1070 1114 1364 1470
Current Ratio 1.6 1.8 2.3 2.0 1.7 2.2 1.9 2.1 2.0 1.9
Long-Term Debt 2062 1635 1603 1613 1455 1604 1604 1598 4783 4254
LTD-to-Net Income 12.1 2.9 3.9 5.4 4.2 11.8 3.8 2.5 10.9 3.7
          Â
Cash-Flows and Other Financial Data          Â
Operating Cash-Flows 494 769 609 732 653 758 575 625 1128 1297
Capital Expenditures 248 343 405 529 634 310 243 457 465 483
Free Cash-Flows 246 426 204 203 9 440 325 159 658 809
Return on Assets 3% 10% 7% 5% 6% 3% 7% 11% 5% 10%
Return on Equity 15% 40% 22% 15% 19% 9% 27% 37% 18% 35%
Return on Investment 7% 19% 14% 10% 12% 6% 16% 22% 10% 16%

Free Cash-Flow to Equity Estimation

A company’s fair value estimate can be calculated as the present value of expected future free cash-flows to equity. Free cash-flows to equity represent the amount of cash-flows available to common stockholders after all operating expenses, interest and principal payments to lenders have been paid and necessary investments in capital equipment and working capital have been made to maintain and grow operations.

Here we estimate fair value in 5 steps:

(1) We forecast the firm’s free-cash flows to equity for the next 10 years using econometric processes;

(2) We discount those cash-flows to the present;

(3) Calculate a terminal value for the firm 10 years out based on a long-term expected growth rate and terminal discount rate and discount it to the present;

(4) Add the discounted terminal value to the discounted value of free-cash flows to equity over the next 10 years; and

(5) Divide the present value of all cash-flows by the number of shares outstanding.

Free cash-flow estimates are presented in Table 2. Table 3 presents valuation results and Table 4 presents a valuation matrix.

Table 2: Free Cash-Flow to Equity Estimation

 Historical Year End Projected Year End
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Revenue 7178 8102 9350 9701 10064 10442 10833 11240 11577 11924 12282 12650 13030
-COGS 5609 6340 6574 7178 7448 7727 8017 8317 8567 8824 9089 9361 9642
Gross Profit 1569 1762 2776 2522 2617 2715 2817 2922 3010 3100 3193 3289 3388
Margin % 22% 22% 30% 26% 26% 26% 26% 26% 26% 26% 26% 26% 26%
-Operating Expense 632 962 914 776 805 940 975 1124 1158 1192 1351 1392 1433
EBIT 937 800 1862 1746 1812 1775 1842 1798 1852 1908 1842 1898 1954
Income Before Tax 881 649 1679 1552 1610 1566 1625 1574 1621 1669 1597 1645 1694
             Â
Net Inc./Starting Line 647 444 1172 1086 1127 1096 1138 1101 1135 1169 1118 1151 1186
             Â
 Free Cash Flow to Equity
+Dep & Amort 273 360 433 460 471 489 507 526 542 558 575 592 610
% of revenue 4% 4% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5% 5%
+Deferred taxes -22 48 331 -65 75 78 81 84 86 89 92 94 97
% of revenue 0% 1% 4% -1% 1% 1% 1% 1% 1% 1% 1% 1% 1%
+Other non-cash -37 -139 69 -423 61 159 22 13 9 37 11 22 8
% of revenue -1% -2% 1% -4% 1% 2% 0% 0% 0% 0% 0% 0% 0%
-WC investments -203 54 -217 -327 -120 -124 -129 -134 -138 -142 -146 -150 -155
% of revenue -3% 1% -2% -3% -1% -1% -1% -1% -1% -1% -1% -1% -1%
-Cap expenditures -457 -465 -483 -729 -611 -634 -658 -682 -703 -724 -746 -768 -791
% of revenue -6% -6% -5% -8% -6% -6% -6% -6% -6% -6% -6% -6% -6%
+Net borrowings -37 1644 -530 -34 -41 -42 -44 -45 -47 -48 -50 -51 -53
% of revenue -1% 20% -6% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
             Â
FCF-to-Equity 131 2307 284 583 961 924 958 916 943 971 914 942 970

Table 3: Valuation Results

Model Inputs & Results
Long-term growth rate 3%
Terminal discount rate 9%
Terminal value ($M) 16655
Discounted terminal value ($M) 7035
Discounted FCFE (t1-t10) ($M) 6145
Cash ($M) 237
Diluted weighted average shares (M) 157
Fair value $85.73
Market price $75.14
Margin-of-safety (%) 14%

Table 4: Valuation Matrix

Valuation Matrix Terminal Discount Rate
8% 9% 10%
Terminal Growth Rate 2% 89.59 78.94 71.25
3% 99.93 85.73 75.95
4% 115.44 95.25 82.21
5% 141.28 109.52 90.97

Conclusion

EMN’s per share earnings in 2013 were $7.44. Historical earnings per share grew at an annual rate of approximately 24% per year since 2004. EMN’s sales per share in 2013 were $59.74. We project that sales will grow at a rate of about 3.4% per year between 2014 and 2023. We expect stable gross margins but compressing net margins. Interest expenses and capital expenditures will remain at recent historical levels in the amounts of approximately 2% and 6% of sales respectively. Our fair value estimate of EMN equals $85.73, suggestig that EMN is underpriced by about 14%.